The subgroup analysis in adult breast cancer patients indicates that crofelemer achieved significant results in this subgroup. A second poster presentation related to the OnTarget trial ...

today shared the Company’s poster presented at the European Society for Medical Oncology’s (“ESMO”) Breast Cancer meeting on May 14-17, 2025, in Munich, Germany. A copy of the poster is ...

Breast cancer is the leading cause of cancer death ... mystery you only hear about on an old episode of “Grey’s Anatomy.” Although it’s more common in younger women, about half of the ...

A large study showed that for most patients, having both breasts removed after cancer was detected in one made no difference. By Gina Kolata For the more than 310,000 women diagnosed with breast ...

today shared the Company's poster presented at the European Society for Medical Oncology's ("ESMO”) Breast Cancer meeting on May 14-17, 2025, in Munich, Germany. A copy of the poster is available at ...